RAMBALDI, ALESSANDRO
RAMBALDI, ALESSANDRO
Dipartimento di Oncologia ed Emato-Oncologia
Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL
2024 G. Gritti, S. Ferrari, F. Lussana, A.M. Barbui, F. Landi, M. Rondi, A. Putelli, F. Ballardini, G. Quaresmini, M. Paganessi, C. Pavoni, A. Ghirardi, E. Gotti, C. Capelli, J. Golay, M. Introna, A. Rambaldi
Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation
2024 M.C. Finazzi, A. Weber, C. Pavoni, A. Grassi, M.C. Micò, A. Algarotti, F. Lussana, A. Rambaldi
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes
2024 T. Barbui, A. Carobbio, V. De Stefano, A. Alvarez-Larran, A. Ghirardi, G. Carioli, F. Fenili, E. Rossi, F. Ciceri, M. Bonifacio, A. Iurlo, F. Palandri, G. Benevolo, F. Pane, A. Ricco, G. Carli, M. Caramella, D. Rapezzi, C. Musolino, S. Siragusa, E. Rumi, A. Patriarca, N. Cascavilla, B. Mora, E. Cacciola, L. Calabresi, G.G. Loscocco, P. Guglielmelli, F. Gesullo, S. Betti, F. Ramundo, F. Lunghi, L. Scaffidi, C. Bucelli, D. Cattaneo, N. Vianelli, M. Bellini, M.C. Finazzi, G. Tognoni, A. Rambaldi, A.M. Vannucchi
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group
2024 N. Kröger, A. Bacigalupo, T. Barbui, M. Ditschkowski, N. Gagelmann, M. Griesshammer, V. Gupta, N. Hamad, C. Harrison, J.C. Hernandez-Boluda, S. Koschmieder, T. Jain, J. Mascarenhas, R. Mesa, U.R. Popat, F. Passamonti, N. Polverelli, A. Rambaldi, M. Robin, R.B. Salit, T. Schroeder, B.L. Scott, R. Tamari, A. Tefferi, A.M. Vannucchi, D.P. Mclornan, G. Barosi
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience
2024 M. Castelli, M.C. Micò, A. Grassi, A. Algarotti, F. Lussana, M.C. Finazzi, B. Rambaldi, C. Pavoni, G. Rizzuto, P. Tebaldi, F. Vendemini, M. Verna, S. Bonanomi, A. Biondi, A. Balduzzi, A. Rambaldi, G. Gotti
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial
2024 G. Cavallaro, A. Grassi, C. Pavoni, M.C. Micò, A. Busca, I.M. Cavattoni, S. Santarone, C. Borghero, A. Olivieri, G. Milone, P. Chiusolo, P. Musto, R. Saccardi, F. Patriarca, F. Pane, G. Saporiti, P. Rivela, E. Terruzzi, R. Cerretti, G. Marotta, A.M. Carella, A. Nagler, D. Russo, P. Corradini, P. Bernasconi, A.P. Iori, L. Castagna, N. Mordini, E. Oldani, C. Di Grazia, A. Bacigalupo, A. Rambaldi
Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center study
2024 A. Condorelli, M. Frigeni, G. Quaresmini, S. Salmoiraghi, C. Pavoni, A. Grassi, M. Raviglione, A. Civini, A. Putelli, F. Lussana, M.C. Finazzi, A. Algarotti, M.C. Micò, O. Spinelli, A. Rambaldi
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT
2024 C. Gurnari, L. Koster, L. Baaij, M. Heiblig, I. Yakoub-Agha, M. Collin, J. Passweg, C.E. Bulabois, A. Khan, M. Loschi, F. Carnevale-Schianca, E. Crisà, D. Caravelli, J. Kuball, F. Saraceni, A. Olivieri, A. Rambaldi, A.G. Kulasekararaj, P.J. Hayden, M. Badoglio, F. Onida, C. Scheid, F. Franceschini, A. Mekinian, S. Savic, M.T. Voso, J. Drozd-Sokolowska, J.A. Snowden, K. Raj, T. Alexander, M. Robin, R. Greco, D.P. Mclornan
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera
2023 T. Barbui, A.M. Vannucchi, V. De Stefano, A. Carobbio, A. Ghirardi, G. Carioli, A. Masciulli, E. Rossi, F. Ciceri, M. Bonifacio, A. Iurlo, F. Palandri, G. Benevolo, F. Pane, A. Ricco, G. Carli, M. Caramella, D. Rapezzi, C. Musolino, S. Siragusa, E. Rumi, A. Patriarca, N. Cascavilla, B. Mora, E. Cacciola, C. Mannarelli, G.G. Loscocco, P. Guglielmelli, F. Gesullo, S. Betti, F. Lunghi, L. Scaffidi, C. Bucelli, N. Vianelli, M. Bellini, M.C. Finazzi, G. Tognoni, A. Rambaldi
High-resolution Nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias
2023 A. Magi, G. Mattei, A. Mingrino, C. Caprioli, C. Ronchini, G. Frigè, R. Semeraro, D. Bolognini, A. Rambaldi, A. Candoni, E. Colombo, L. Mazzarella, P.G. Pelicci
Optimal Use of Novel Immunotherapeutics in B-Cell Precursor ALL
2023 F. Lussana, G. Cavallaro, P. De Simone, A. Rambaldi
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study
2023 G. Maggioni, M. Bersanelli, E. Travaglino, A. Alfonso Piérola, A. Kasprzak, A. Sangerman Montserrat, E. Sauta, C. Sala, T. Matteuzzi, M. Meggendorfer, M. Gnocchi, L. Zhao, C.A. Tentori, K. Nachtkamp, D. Dall'Olio, E. Mosca, M. Ubezio, A. Campagna, A. Russo, G. Rivoli, M. Bernardi, L. Borin, M.T. Voso, M. Riva, E. Oliva, M. Zampini, E. Riva, E. Saba, S. D'Amico, L. Lanino, B. Tinterri, F. Re, M. Bicchieri, L. Giordano, G. Angelotti, P. Morandini, A.S. Kubasch, F. Passamonti, A. Rambaldi, V. Savevski, A. Santoro, A.A. van de Loosdrecht, A. Brogi, V. Santini, S. Kordasti, G. Sanz, F. Sole, N. Gattermann, W. Kern, U. Platzbecker, L. Ades, P. Fenaux, T. Haferlach, G. Castellani, U. Germing, M. Diez-Campelo, M.G. Della Porta
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
2023 E. Sauta, M. Robin, M. Bersanelli, E. Travaglino, M. Meggendorfer, L. Zhao, J.C. Caballero Berrocal, C. Sala, G. Maggioni, M. Bernardi, C. Di Grazia, L. Vago, G. Rivoli, L. Borin, S. D'Amico, C.A. Tentori, M. Ubezio, A. Campagna, A. Russo, D. Mannina, L. Lanino, P. Chiusolo, L. Giaccone, M.T. Voso, M. Riva, E.N. Oliva, M. Zampini, E. Riva, O. Nibourel, M. Bicchieri, N. Bolli, A. Rambaldi, F. Passamonti, V. Savevski, A. Santoro, U. Germing, S. Kordasti, V. Santini, M. Diez-Campelo, G. Sanz, F. Sole, W. Kern, U. Platzbecker, L. Ades, P. Fenaux, T. Haferlach, G. Castellani, M.G. Della Porta
Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy
2022 S.K. Khaled, K. Claes, Y.T. Goh, Y.L. Kwong, N. Leung, W. Mendrek, R. Nakamura, J. Sathar, E. Ng, N. Nangia, S. Whitaker, A. Rambaldi
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19
2022 T. Barbui, A. Carobbio, A. Ghirardi, A. Iurlo, M.A. Sobas, E.M. Elli, E. Rumi, V. De Stefano, F. Lunghi, M. Marchetti, R. Daffini, M. Gasior Kabat, B. Cuevas, M.L. Fox, M.M. Andrade-Campos, F. Palandri, P. Guglielmelli, G. Benevolo, C. Harrison, M. Foncillas, M. Bonifacio, A. Alvarez-Larran, J. Kiladjian, E. Bolaños Calderón, A. Patriarca, K. Quiroz Cervantes, M. Griesshammer, V. Garcia-Gutierrez, A. Marin Sanchez, E. Magro Mazo, G. Carli, J.C. Hernandez-Boluda, S. Osorio, G. Carreno-Tarragona, M. Sagues Serrano, R. Kusec, B. Navas Elorza, A. Angona, B. Xicoy Cirici, E. Lopez Abadia, S. Koschmieder, D. Cattaneo, C. Bucelli, E. Cichocka, A.K. de Nałęcz, F. Cavalca, O. Borsani, S. Betti, M. Bellini, N. Curto-Garcia, A. Rambaldi, A.M. Vannucchi
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients : Final analysis of a prospective randomized trial
2022 D.W. Beelen, M. Stelljes, P. Reményi, E. Wagner-Drouet, P. Dreger, W. Bethge, F. Ciceri, F. Stölzel, C. Junghanß, H. Labussiere-Wallet, K. Schaefer-Eckart, G.U. Grigoleit, C. Scheid, F. Patriarca, A. Rambaldi, D. Niederwieser, I. Hilgendorf, D. Russo, G. Socié, E. Holler, B. Glass, J. Casper, G. Wulf, N. Basara, M. Bieniaszewska, G. Stuhler, M. Verbeek, U. La Rocca, J. Finke, F. Benedetti, U. Pichlmeier, A. Klein, J. Baumgart, M. Markiewicz
Isatuximab monotherapy in patients with refractory T-acute lymphoblastic leukemia or T-lymphoblastic lymphoma: Phase 2 study
2022 N. Boissel, P. Chevallier, V. Doronin, L. Griskevicius, A. Maschan, J. Mccloskey, A. Rambaldi, G. Rossi, A. Sokolov, U. Wartiovaara-Kautto, C. Oprea, G. Abbadessa, A. Gosselin, S. Macé, X. Thomas
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
2022 J.-. Hernandez-Boluda, A. Pereira, N. Zinger, L. Gras, R. Martino, S. Paneesha, J. Finke, A. Chinea, A. Rambaldi, M. Robin, R. Saccardi, A. Natale, J.A. Snowden, P. Tsirigotis, C. Vallejo, G. Wulf, B. Xicoy, D. Russo, J. Maertens, E. Daguindau, S. Lenhoff, P. Hayden, T. Czerw, D.P. Mclornan, I. Yakoub-Agha
Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1-JAK2 positive myeloid sarcoma and acute B-lymphoblastic leukemia
2022 G. Rizzuto, M. Leoncin, S. Imbergamo, D. Taurino, M.C. Mico, M. Tosi, A. Michelato, K. Buklijas, O. Spinelli, F. Lussana, F. Lessi, M. Pizzi, L. Bonaldi, G. Binotto, A. Rambaldi, C. Gurrieri
Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study
2022 A. Candoni, D. Lazzarotto, A. Rambaldi, M.V. Dubbini, P. Bresciani, A. Busca, W. Arcese, A.P. Iori, R. Sorasio, G. Irrera, R. Fanin, F. Ciceri, F. Bonifazi